Samantha S. Ehrlich
Papers
1
Total Citations
2
H-Index
1
About
Dr. Samantha S. Ehrlich is a distinguished clinical researcher whose work centers on developing innovative neoadjuvant trial platforms for prostate cancer treatment. Her primary research focuses on creating standardized frameworks that enable the rapid evaluation of targeted therapies before surgery, ensuring tumor tissue availability for biomarker validation and drug development. Her most notable contribution is the pioneering study "Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer" (2014), which introduced a groundbreaking clinical trial model using Degarelix to suppress testosterone prior to prostatectomy. This work addresses critical unmet needs in prostate cancer drug development by providing a structured approach to assess therapeutic efficacy and molecular profiling. While her citation count remains modest, Dr. Ehrlich's research has significant translational impact, offering a replicable framework that could accelerate the development of novel agents for aggressive prostate cancers. Her dedication to bridging preclinical discoveries with clinical applications makes her a vital contributor to advancing precision oncology.
Research Focus
Key Achievements
Top Papers
- 1